BACKGROUND: Assessing the volemic status of patients undergoing surgery is part of the routine management for the anesthesiologist. This assessment is commonly performed by means of dynamic indexes based on the cardiopulmonary interaction during mechanical ventilation (if available) or by administering a fluid challenge (FC). The FC is used during surgery to optimize predefined hemodynamic targets, the so-called Goal-Directed Therapy (GDT), or to correct hemodynamic instability (non-GDT). METHODS: In this systematic review, we considered the FC components in studies adopting either GDT or non-GDT, to assess whether differences exist between the 2 approaches. In addition, we performed a meta-analysis to ascertain the effectiveness of dynamic indexes pulse pressure variation (PPV) and stroke volume (SV) variation (SVV), in predicting fluid responsiveness. RESULTS: Thirty-five non-GDT and 33 GDT studies met inclusion criteria, including 5017 patients. In the vast majority of non-GDT and GDT studies, the FC consisted in the administration of colloids (85.7% and 90.9%, respectively). In 29 non-GDT studies, the colloid infused was the 6% hydroxyethyl starch (6% HES; 96.6% of this subgroup). In 20 GDT studies, the colloid infused was the 6% HES (66.7% of this subgroup), while in 5 studies was a gelatin (16.7% of this subgroup), in 3 studies an unspecified colloid (10.0% of this subgroup), and in 1 study albumin (3.3%) or, in another study, both HES 6% and gelatin (3.3%). In non-GDT studies, the median volume infused was 500 mL; the time of infusion and hemodynamic target to assess fluid responsiveness lacked standardization. In GDT studies, FC usually consisted in the administration of 250 mL of colloids (48.8%) in 10 minutes (45.4%) targeting an SV increase >10% (57.5%). Only in 60.6% of GDT studies, a safety limit was adopted. PPV pooled area under the curve (95% confidence interval [CI]) was 0.86 (0.80-0.92). The mean (standard deviation) PPV threshold predicting fluid responsiveness was 10.5% (3.2) (range, 8%-15%), while the pooled (95% CI) sensitivity and specificity were 0.80 (0.74-0.85) and 0.83 (0.73-0.91), respectively. SVV pooled area under the curve (95% CI) was 0.87 (0.81-0.93). The mean (standard deviation) SVV threshold predicting fluid responsiveness was 11.3% (3.1) (range, 7.5%-15.5%), while the pooled (95% CI) sensitivity and specificity were 0.82 (0.75-0.89) and 0.77 (0.71-0.82), respectively. CONCLUSIONS: The key components of FC including type of fluid (colloids, often 6% HES), volume (500 and 250 mL in non-GDT studies and GDT studies, respectively), and time of infusion (10 minutes) are quite standardized in operating room. However, pooled sensitivity and specificity of both PPV and SVV are limited. (Anesth Analg 2018;127:1353-64) Fluid Challenge During Anesthesia: A Systematic Review and Meta-analysis 
P erioperative fluid therapy is a key component of the management of surgical patients and dedicated algorithms and protocols are nowadays part of the included into routine intraoperative and perioperative care. 1, 2 Conventional fluid administration, aimed at balancing fluid intake and output, should be distinguished from the acute treatment of hemodynamically unstable patients. 1, 3 Several dynamic tests have been proposed to predict whether or not fluid infusion would increase the cardiac output (CO), such as the fluctuations of pulse pressure or stroke volume (SV) during mechanical ventilation or the increase in right preload by modifying the position of the patient 4 or interrupting positive pressure ventilation. 5 The fluid challenge (FC) consists in assessing the hemodynamic effects of giving fluid in a limited period of time. 6 By allowing to restore fluid depletion when indicated, while minimizing the risk of overloading, 3 the FC is routinely used to assess fluid depletion in surgical patients. 6 In the operating room, fluids may be administered either to correct an unexpected episode of hypotension or hypovolemia 1, [7] [8] [9] or in small aliquots protocolized to optimize hemodynamics, the so-called Goal-Directed Therapy (GDT). 10, 11 Type, amount and duration of the infusion, interval between FC administration and fluid responsiveness assessment, indices, and relative thresholds for determining the hemodynamic response are all important issues potentially affecting the outcome of the FC. A recent study considering adult critically ill patients, however, highlighted the lack of definite standards for FC administration and evaluation in intensive care unit (ICU). 12 It remains unclear, however, what the best approach to FC administration should be and, in fact, wide variability exists at this regard among studies performed both in the perioperative setting and in the ICU. 12 Aim of this systematic review is to describe and compare the modality of FC administration in non-GDT and GDT studies performed in patients undergoing surgery, considering indications, hemodynamic targets and thresholds for fluid responsiveness assessment, use of safety limits, fluid type, dose, and time of infusion. In addition, we evaluated the use of 2 dynamic predictors of fluid responsiveness, pulse pressure variation (PPV) and SV variation (SVV), to guide FC administration and performed a meta-analysis to ascertain the reliability of both of these indexes in predicting fluid responsiveness.
METHODS Study Selection and Inclusion Criteria
FC was considered as the infusion of a definite quantity of fluid of a specific quality in a period of time (expressed either as span or infusion rate), administered to assess variations of a hemodynamic variable. Studies in whom the FC was not defined or standardized were excluded.
All articles in English language, including adult patients, without restrictions related to type of surgery and surgical risk, and published in indexed scientific journals in the last 20 years were considered (January 1, 1997 to January 1, 2017). Reviews, case reports, and studies published in abstract form were excluded. Only 2-harm GDT studies (treatment-control subgroups) were included.
Search Strategy
Three authors (A.M., E.B., and C.P.) independently searched MEDLINE, EMBASE, and Cochrane Database of Systematic Reviews using the following keywords and their related MeSh terms: "fluid challenge," "fluid responsiveness," "stroke volume variation," "pulse pressure variation," "dynamic indices OR indexes," "intraoperative fluid optimization," "surgery" "directed therapy," "goal-directed therapy," "fluid therapy," "goal oriented," "goal targeted," and "fluid optimization." References of included papers and review articles were also examined to identify additional studies missed during the primary search (Supplemental Digital Content, Document, http://links.lww.com/AA/C594).
Data Extraction
All articles were independently evaluated by couple of researchers who reported all collected data in an EXCEL (Microsoft, Redwood, MS) spreadsheet specifically designed for the study purposes. When data were not available, the corresponding authors were contacted. In case of disagreement for the article selection or variables to be retrieved, it was requested the intervention of a third, senior, expert (P.N., G.S.).
Whenever possible, the mean body surface area and weight of the enrolled samples were used to recalculate the nonindexed variables, reporting the corresponding indexed values (ie, from CO and SV to cardiac index and SV index [SVI] ) and the volume/weight (mL/kg) reporting the absolute volume (mL). All the hemodynamic changes associated to FC administration were reported as percentage of variation with respect to baseline values.
Statistical Analysis
Statistical analyses were performed on the statistical figures reported in the selected articles. On this basis, the statistical unit of observation for the variables was the single study. The statistical software STATA13 (StataCorp, College Station, TX), StatsDirect version 3 (StatsDirect Ltd, Altrincham, UK), and Metadisc version 1.4 (http://www.hrc.es/investigacion/metadisc.html) were used to perform all the statistical analyses. Quantitative variables were summarized with means (standard deviations [SDs]) or medians (interquartile ranges [IQRs]) according to their distribution. Student t test or Mann-Whitney test was computed to find differences between non-GDT and GDT studies. Two-tailed P values <.05 were considered significant.
A meta-analysis of the PPV and SVV values before FC administration was performed, using data obtained from those studies evaluating PPV and SVV reliability in predicting fluid responsiveness by means of a receiving operating characteristics (ROCs) curve approach. Random effects models were used. In-between study heterogeneity was assessed through the I 2 indicator. Bias assessment graphs were plotted, and Egger regression analysis was used to evaluate the publication bias. The area under the curve (AUC) of pooled ROC curves was reported with 95% confidence interval (95% CI).
Epidemiological Design and Characteristics of the Population
Only studies published after 2001 met inclusion criteria (Tables 1-2) . Overall, non-GDT studies recruited 1436 patients, with a median (IQR) of 38 (31-59) patients enrolled, 35 of whom were analyzed. The median (IQR) number of FCs administered was 40 for each study. Overall, the mean (SD) number of fluid responders was 57.7% (14.3%).
GDT studies were all randomized controlled trials and included 3581 patients with a higher median (IQR) number of enrolled [92 (49- In 13 non-GDT (37.1%) studies, FC was infused "after induction" of the general anesthesia, while in 8 (22.8%) studies, FC was infused during a specific surgical timing; in 7 (20.0%), timing was not detailed; finally, in 5 (14.2%), FC was administered following the decision of the attending anesthetist, based on specific 16, 39 (10%-20% drop in mean arterial pressure or cardiac index) or undefined criteria (Tables 3 and 4) . 13, 15, 23 In 24 (68.5%) non-GDT studies, either SVI or SV were used to assess fluid responsiveness; in 9 of these studies, a positive response was defined by an increase of ≥15%, in 7 of ≥10%, in 4 of ≥25%, in 2 of ≥20%, in one of ≥12%, and in another one of ≥5%. In the remaining 11 (31.5%) studies, the hemodynamic variables used to assess fluid responsiveness were either cardiac index or CO; in 7 of these studies, a positive response was defined by an increase of ≥15%, in 3 of >15%, and in 1 of ≥10%.
Three (9.1%) GDT studies administered the FC after the sequential evaluation of cardiac index, SVI, and SVV and one of cardiac index and SVI, while in 19 (57.5%), the GDT protocol was guided by a 10% increase of SV or SVI (in 5 of these studies the corrected systolic flow time [FTC] <0.35 seconds was also considered together with SV increase, and in 2 the SVV >10% or >13%); in 5 (15.1%) by SVV values ranging from 10% to 13%, in the remaining 6 (18.1%) by the variability index, PPV, mean arterial pressure, central venous oxygen saturation, or wedge pressure. In 12 of 19 GDT studies assessing an SV increase >10%, 50, 52, 55, 56, 59, 60, 63, [65] [66] [67] 73, 74 the first bolus was administered regardless of predetermined cutoff hemodynamic values suggesting fluid depletion.
A safety limit indicating the absence of hemodynamic response to FC and risk of futile fluid administration was present in 60.6% and 0% of GDT and non-GDT studies, respectively. (Tables 3 and 4 ). In 29 non-GDT studies, the colloid infused was the 6% hydroxyethyl starch (HES 6%, 96.6% of this subgroup), while in 1 study the type of colloid was not specified. In 20 GDT studies, the colloid infused was the HES 6% (66.7% of this subgroup), while in 5 studies was a gelatin (16.7% of this subgroup), in 3 studies an unspecified colloid (10.0% of this subgroup), and in one study albumin (3.3%) or, in another study, both HES 6% and gelatin (3.3%). Overall, the use of HES 6% was not different between non-GDT and GDT studies (82.8% vs 63.6%, respectively; P = .13).
In 16 (45.7%) non-GDT studies, the volume administered was 7.5 mL/kg (7-10 mL/kg). In 11 of these studies reporting the mean body weight of the enrolled population, the median (IQR) volume was 619 mL (655-538 mL). In the remaining 19 non-GDT studies, 12 (34.2%) infused 500 mL.
In 16 (48.8%) GDT studies, FC consisted of 250 mL and the median (IQR) FC volume infused, while in 9 (27.2%), the FC volume administered was 3 mL/kg, but in 2 of these only the first bolus consisted of 7 mL/kg. Only 2 GDT studies reported the mean body weight and the mean (SD) calculated FC volume was 224 mL (24 mL). The median (IQR) volume infused was significantly higher in non-GDT as compared to GDT studies [500 mL (467-551 mL) vs 250 mL (150-250 mL); P < .0001].
Three (8.6%) non-GDT studies reported an infusion rate of 1 mL/kg/min. In the remaining 32, the FC was administered in 30 minutes in 7 (21.8%) studies, in 20 minutes in 2 (6.2%) studies, in 13 minutes in 1 (3.1%) study, in 10 minutes, in 15 studies (46.8%), in 5 minutes in 4 (12.5%) studies, in 3 minutes in 1 (3.1%) study, and in 2 minutes in 2 (6.2%) studies. The median (IQR) time of infusion was 10 minutes (5-20 minutes). In 15 (45.4%) GDT studies the FC was administered in a median (IQR) time of 10 minutes (5-15 minutes), while in the others as "bolus". Mean (SD) infusion time was not significantly different between non-GDT and GDT (14 minutes [9 minutes] vs 9 minutes [5 minutes], respectively; P = .07).
The rate of infusion was calculated in 28 (80.0%) non-GDT studies and in 12 (36.3%) GDT studies reporting both volume and time of FC administration. In non-GDT studies, the mean (SD) rate of infusion was 49.2 mL/min (29.1 www.anesthesia-analgesia.org 1357 mL/min), while in GDT studies was 36.5 mL/min (31.4 mL/min) (P = .07).
Meta-analysis: Pooled ROC Curve of PPV and SVV
PPV and SVV were tested as dynamic indexes of fluid responsiveness only in non-GDT studies. The reported values of the ROC curve analysis fitted the criteria for metaanalysis in 10 non-GDT studies for PPV, including 366 patients and infusing 390 FCs, 15, 16, 22, 25, 26, 28, 31, 33, 35, 38, 44 and in 16 non-GDT studies for SVV, including 816 patients and infusing 1020 FCs [16] [17] [18] [19] [25] [26] [27] 29, 30, [34] [35] [36] [37] [38] 44, 46 (see Table 5 ). For the PPV, the pooled AUC (95% CI) was 0.86 (0.80-0.92). The mean (SD) threshold of PPV predicting fluid responsiveness was 10.5% (3.2%), ranging from 8% 16 to 15%. 28 The pooled (95% CI) sensitivity and specificity were 0. For the SVV, the pooled AUC (95% CI) was 0.87 (0.81-0.93). The mean (SD) threshold of SVV predicting fluid responsiveness was 11.3% (3.1%), ranging from 7.5% 26 to 15.5%. 17 The pooled (95% CI) sensitivity and specificity were 0. 
DISCUSSION
The present study shows that in surgical patients FC consists, in the majority of the cases, in the administration of colloids, more frequently in aliquots of 500 mL (single bolus, non-GDT studies) or 250 mL (multiple boluses, GDT studies) administered in about 10 minutes. SVI or SV changes are used to assess fluid responsiveness, but the threshold of >10% is standardized only in GDT studies. The reliability of PPV and SVV in predicting fluid responsiveness is limited.
There is increasing evidence that fluid management affects the outcome of critically ill and surgical patients, 80 and the debate regarding the correct fluid management in operating room is still open. 7, 10, 11, 81, 82 Irrespectively to the applied fluid therapy policy (GDT, zero balance, or fluid restriction), however, intraoperative fluid administration should be titrated on hemodynamic parameters to prevent fluid overload, 80 while the absolute volume of www.anesthesia-analgesia.org
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Colloids were overall used in the 86% of the studies included in the review. This is somewhat surprising, considering that several studies showed, in critically ill patients, the use of colloids being associated with an increased risk of renal failure and death. [83] [84] [85] Worth mentioning, however, recent meta-analysis do not confirm these caveats in surgical patients. 86, 87 In principle, the infusion of colloids should be associated with a long-lasting hemodynamic effect on SV, reducing intraoperative fluid administration, 88 and increasing microcirculatory blood flow. 89, 90 While the hemodynamic effect of 250 mL crystalloids is dissipated within 10 minutes, 91 the macromolecules of colloids are retained in the intravascular compartment with a phase of distribution dependent on patient's volemic status. 92 Indeed, a number of GDT studies show that intraoperative SV optimization through colloids, predominantly starch solutions suspended in crystalloids, associated with background crystalloid infusions or inotropes infusion, results in improved postoperative outcomes. 88 In 36.3% of the GDT trials, 50, 52, 55, 56, 59, 60, 63, [65] [66] [67] 73, 74 the first FC was administered regardless of the values of dynamic or static indexes of fluid responsiveness and, then, was repeated according to SV response. The number of fluid responders to the first bolus was not assessed in any GDT trial. However, Bartha et al, 93 in a subanalysis of a GDT aimed to SV and oxygen delivery optimization and performed in patients with hip fracture, 63 reported a 38.5% and a 8.5% of responders to the first and the second FC (3 mL/kg of colloids) respectively, while only 13.8% of controls responded to clinician-guided FC, consisting of Ringer acetate or colloids, before spinal anesthesia.
A range of SVV from 10% to 13% and safety limits between 8% and 13% have been used in 15.1% of the studies (Table 4 ). The hemodynamic targets and thresholds adopted are variable among studies. Despite 63.3% of the studies evaluated SVV variations after FC administration, a 10% target threshold was adopted in 38.2% of the studies. Indeed, the choice of a predefined threshold could be inaccurate, the "gray zone" of inaccuracy of the dynamic indexes ranging between 9% and 13%. The AUC of the study was not statistically significant, and the optimal cutoff value, the sensitivity, and the specificity were not reported.
The lack of a definitive threshold might influence the number of fluid responders because the ROC curve approach is constructed using a reference gold standard test to define the positive or negative result. For example, the definition of fluid responsiveness could be affected by the threshold adopted because a patient considered responder for a >10% increase in SV may not be responder if the threshold is raised up to >15%. 94 Regarding the meta-analysis of the dynamic index of fluid responsiveness, in the literature, the reliability of PPV and SVV in operating room has been investigated only in few systematic reviews and, to our knowledge, the present review is the largest ever conducted. Marik et al 95 report for PPV an AUC of 0.93 (95% CI, 0.92-0.94) in a subgroup of studies where a mean intraoperative tidal volume >8 mL/ kg was delivered. In this meta-analysis, only 5 studies after induction of anesthesia were included, while 10 after surgery. In 2011, Zhang et al 96 reported an AUC of 0.94 (95% CI, 0.907-0.945) for SVV in 8 surgical studies. However, as pointed out by the authors, because of the small number of included studies, the cumulative AUC of SVV would drop down to 0.84 by excluding only 1 study reporting an AUC of 0.99. 36 Furthermore, as suggested by our findings, publication bias/small study effects should be also considered.
Interestingly, despite most of the validity criteria affecting dynamic indexes reliability, such as tidal volume, heart rateto-respiratory rate ratio, presence of spontaneous breathing activity, pulmonary and chest wall compliance, and right ventricle function, should be more frequently respected in the operating room rather than in ICU, 97 pooled sensitivity and specificity of both PPV (0.79 and 0.84, respectively) and SVV (0.80 and 0.77, respectively) are quite limited. A more recent approach to fluid responsiveness introduced the flexible gray-zone concept 98 instead of the simplistic ROC curve application to define fixed cutoffs to discriminate responders and nonresponders. This gray-zone approach identifies a range of inaccuracy, in which up to 25% of PPV values of surgical patients are included. 98 The results of this metaanalysis suggest caution in relying on baseline PPV and SVV to assess fluid responsiveness, encouraging the use in operating room of recently introduced hemodynamic tests, such as the end-expiratory occlusion and the mini-FC tests.
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CONCLUSIONS
In surgical patients, much more than in ICU patients, some FC key components, such as type of fluid (colloids, often 6% HES), volume (500 and 250 mL in non-GDT and GDT studies, respectively), and time of infusion (10 minutes) are quite standardized. In non-GDT studies, thresholds for assessment of fluid responsiveness are not standardized and safety limits are not used, while GDT studies frequently adopt a >10% increase of SV or SVI with safety limits. The pooled sensitivity and specificity of PPV and SVV are limited, suggesting caution when using these indexes of fluid responsiveness in the operating room. E
